How Ph.D. was paid
$14M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Udit Batra, Ph.D.President & CEO | $1,150,000 | $7,430,247 | $2,999,922 | $2,371,875 | $21,000 | $13,973,044 |
| Amol ChaubalSVP & CFO | $650,000 | $1,732,598 | $689,950 | $750,750 | $21,000 | $3,844,298 |
| Jianqing Y. BennettSVP, TA & Clinical Division | $633,000 | $1,280,262 | $509,858 | $522,225 | $21,000 | $2,966,345 |
| Robert Carpio IIISVP, Waters Division | $600,000 | $1,129,966 | $449,988 | $618,750 | $21,000 | $2,819,704 |
What changed and why
- $14MCEO total compensation increased to $13,973,044 in fiscal year 2025.
- 7%Full-year sales grew 7% on reported and constant currency bases.
- 11%Adjusted earnings per share increased 11% to $13.13.
- 55%Long-term incentives were rebalanced to 55% PSUs, 30% stock options, and 15% RSUs.
- 82%Shares voted in favor of the say-on-pay proposal represented approximately 82% of votes cast.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.